Course curriculum

    1. Crescentic Glomerulonephritis

    2. Targeting Glomerular Injury with Sparsentan to Preserve Kidney Function in Patients with IgA Nephropathy

    3. Belatacept in Kidney Transplantation: Clinical Practice

    4. Bartonella endocarditis-associated glomerulonephritis. Our experience and a pooled analysis

    5. The Ethics of Xenotransplantation in the Era of Artificial Intelligence and Quantum Algorithms

    6. Kidney Pathology Challenging Cases, Challenging Samples

    7. HCV+ Kidney Transplantation

    8. ANCA-Associated Vasculitis 2024

    9. APOL1-Mediated Kidney Disease in Autoimmune Conditions

    10. Equity in Kidney Transplantation

    11. Updates in Membranous Nephropathy

    12. Obesity-Related Glomerulopathy and Diabetic Nephropathy: Similarities and Differences

    13. Biopsy or Not Biopsy in Patients with Diabetes and Kidney Disease

    14. Update on Treatment of ANCA-Associated Vasculitis and Future Perspectives

    15. Genetic Evaluation of Living Donor Candidates

    16. Not Everything Under One Umbrella

    17. Tissue Transcriptomics in Kidney Transplant Rejection — Continued Surprises

    18. What is Really Causing Disparities in Access to Kidney Transplantation

    19. Rituximab Related Complications A Closer Look at a Familiar Tool

    20. Reaching for Primary FSGS and studying their disease journey within a diverse population in the USA

    21. Focal and Segmental Gomerulosclerosis. A need for better phenotyping patients

    22. Chronic AMR in Kidney Transplant Recipients

    23. Prophylaxis in Glomerular Disease

    24. Progressing Towards Automated Banff Scoring

    25. IgAN and IgA Dominant Glomerulopathies - KM55 as a Tissue Biomarker for Differentiation

    26. Protective Effect of Variant p.N264K in the APOL1 Gene Against APOL1 Medicated kidney disease (AMKD)

    27. Complement in Kidney Transplantation

    28. Morpho-omic Integration and Clinical Deployment

    29. Organized Deposits- Differential Diagnosis and Histopathology

    30. Integrating spatial omics and computationally derived characteristics of functional tissue units and cells (FUSION)

    31. Updates in Transplant Onconephrology

    32. Histo-tools on NEPTUNE and CureGN Repositories

    33. Lupus Nephritis

    34. DNAJB9-Fibrillary Glomerulonephritis

    35. The Evolution of the Renal Biopsy Evaluation

    36. Updates in Complement Biology in Health, Disease, and Therapeutics

    37. CAR T Cell Therapy for Autoimmune Disease

    38. Membranous Nephropathy: Novel Treatments Paradigms

    39. Rituximab in Adult Podocytopathies - The rationale for its use, efficacy data, and outlook

    40. The Challenge of Deceased Donor Kidney Utilization

    41. SPARSENTAN In IgA Nephropathy: An Update On The Clinical Trials

    42. Platelets in Kidney Injury and Repair – insights from preclinical research

    43. Vaccine Responses in Immunocompromised Individuals

    44. Computational Pathology of FSGS and MCD

    45. A Clinical-pathological Approach to Differentiate Primary, Secondary, and Genetic FSGS

    46. The Treatment of IgAN: What’s the Latest?

    1. AA Amyloidosis - 20 years journey to identification AA amyloidosis without systemic inflammation

    2. Lost in Translation: The Lupus Nephritis Classification over the years

    3. Banff 2022: An Update

    4. Hepatitis C Virus-Related Glomerulonephritis - An Update

    5. Tubular Toxins: Origins and Kidney Consequences

    6. AI in Renal Pathology

    7. Renal Amyloidosis: Presentation, Diagnosis, and Management

    8. Apolipoprotein E Gene - Polymorphism and CKD

    9. Current Approaches in the Treatment of MGRS

    10. Pregnancy and Kidney Transplantation

    11. Alport Spectrum Disorders

    12. Renal Manifestations in Rheumatologic Diseases

    13. IgA Nephropathy: Developing a Non-Immunosuppressive Therapy

    14. Kidney Allograft Tolerance: Close to Prime Time?

    15. Atypical Anti-GBM Nephritis

    16. Living Kidney Donation - An Update

    17. Infection, IgA deposits, Crescents, ANCA – the diagnostic conundrum

    18. Discovery of ‘New’ Antigens in Membranous Nephropathy

    19. As far as we can go - From Pathology to Genetics - Interesting cases from the practice

    20. I wasn’t expecting THAT! - When clinical presentation and kidney biopsy disagree with each other, who gets the last word?

    21. BK Virus Nephropathy: An Update

    22. Laboratory Management in Renal Pathology

    23. The Kidney Biopsy: An introduction for nephrologists

    24. What is Behind Granulomatous TIN?

    25. Anti-phospholipid Nephropathy

    26. Proteomics in Kidney Disease

    27. Precision Medicine in Lupus Nephritis

    28. C3 Glomerulopathy - In the Native Kidney and Post- Transplant

    29. Mechanistics of Kidney Allograft Rejection

    30. The Pathology and Pathogenesis of CKDu

    31. Viral Cytokine Storms and Glomerular Disease

    32. Kidney Potpourri - A selection of renal biopsy cases

    33. Precision Medicine - A serology-guided approach to the treatment of PLA2R associated Membranous Nephropathy

    34. Artificial Intelligence and Clinical Decision Support in Kidney Transplantation

    35. Microvascular inflammation of the Kidney Allograft

    36. New Technologies to study - Kidney Disease: Spatial Transcriptomics

    37. Anti Nephrin-Mediated Podocytopathy - More than a Minimal Change

    38. 2023 Challenges in SLE

    39. Translating New Trials in IgAN

    40. 2023 Updates on CMV Management after Kidney Transplant

    41. PGNMID or C3 GN?

    42. Super-Resolution Microscopy and More - Tools revolutionizing Research & Drug Discovery for glomerulopathies

    43. Understanding MPGN and C3 Glomerulopathy

    44. Ethics of pig to human transplants, Artificial intelligence, and Why the future is porcine

    1. Secondary IgA Nephropathy - Reality or Illusion

    2. Emerging Science in Kidney Disease with Pfizer

    3. Bench-to-Bedside-Bench Studies in Familial Nephrotic Syndrome

    4. Renal Allograft Biopsies - How to Deal with the Scofflaws

    5. APOL1 - Toward Precision Medicine Approaches

    6. Lupus Nephritis - To Be or Not to Be

    7. A Clinical Trial in Primary FSGS

    8. Comprehensive Kidney Transplant Care

    9. Chronic Antibody Mediated Rejection - Insights from Spatial Molecular Profiling

    10. IgAN & FSGS

    11. Equity, Utility, and the Kidney Transplant Allocation System

    12. Complete Digitization of The Kidney Biopsy

    13. Management of ANCA GN

    14. Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant

    15. Non-invasive Monitoring of Kidney Transplant Recipients

    16. Onconephrology Update

    17. The Pathology of Tubulointerstitial Nephritis

    18. Renal Involment in Lymphoproliferative Disorders

    19. APOL1

    20. Kidney Xenotransplantation

    21. Membranous Lupus Nephritis Glom Con

    22. Getting Ready for Flozins

    23. Emerging Therapies for IgA Nephropathy

    24. Transplant Molecular Diagnostics: Cutting Thru the Hype & Promoting Objectivity

    25. Renal Biopsy in a Diabetic Patient

    26. Minimal Change Disease Reimagined

    27. Fireside chat with Dr. Aliza Thompson

    28. Post- transplant Recurrence of Glomerular Diseases

    29. Thrombotic Microangiopathies

    30. Kidney Adverse Effects of Anti-Tumor Therapy

    31. The Molecular Microscope

    32. Lupus Nephritis and Idiopathic Full-House Glomerulonephritis

    33. Thrombotic Microangiopathy - An update for The Practicing Physician

    34. Clinical Trials - Drug Development for All Ages

    35. Immunosuppressive Management of the Kidney Transplant Recipient

    36. MPGN and C3 glomerulopathy

    37. The Value of Electron Microscopy in Renal Pathology

    38. Approaching Nephrotic Syndrome after COVID Immunization

    39. Antibody Mediated Rejection of the Kidney Allograft - A Practical Update

    40. More Than Meets the Eye - Gene Expression Profiling in Kidney Transplant Biopsies

    41. Common Vascular & Endothelial Injuries

    42. Digging Deeper in Renal Pathology

    1. Targeting the Podocyte as a Treatment Approach for FSGS

    2. Nephrotoxic Manifestations of Drugs in the Renal Allograft

    3. Kidney Biopsy in Type 2 Diabetes - Any Novelties?

    4. T-Cell Mediated Rejection - Acute and Chronic Active

    5. Targeting C3 & IC glomerulopathies - Pegcetacoplan

    6. The Renal Pathology of Check Point Inhibitors

    7. Principles in Alloimmunity - Practical Aspects for the Non-transplant Nephrologist

    8. Old and New Ways of Understanding FSGS

    9. COVID-19 Associated Renal Disease - Pathology and New Molecular Insights

    10. The Use of Race in eGFR and More: is it Essential or Race Essentialism?

    11. HLA Typing and Detection of Sensitized Recipients

    12. The Kidney in Aging and the Diagnosis of CKD

    13. Barriers to Women in Medicine, Nephrology, and Academia

    14. Pathology and Clinical Trials

    15. Transplant Onconephrology

    16. Post-transplant Recurrent - Primary Glomerular Diseases

    17. Comorbidities in ANCA- Associated Vasculitis

    18. Pauci-immune - Glomerulonephritis

    19. Lupus Nephritis Trial Design & Execution

    20. COVID-19 Vaccine & GN - Trigger & Shield? Not if but when

    21. The Tissue Patterns of Monoclonal Deposits - PGNMID as a case study

    22. The Tissue Patterns of Monoclonal Deposits - PGNMID as a case study

    23. Viral Infections in the Renal Allograft

    24. Viral Infections in the Renal Allograft

    25. Lupus Nephritis Classification - How can we Improve?

    26. Why is the Diagnosis of "Hypertensive Nephrosclerosis" A Fallacy and a Cop-out?

    27. Trends in European Kidney Transplantation Rates - An International Comparison

    28. The Spectrum of Fibrillary Glomerulonephritis

    29. The Long Road to Glomerular Disease Therapeutics

    30. Prophylaxis in Glomerular Diseases

    31. Hypercalcemia Associated with Immune-Checkpoint Inhibitors

    32. The Banff Kidney Transplant Pathology Classification

    33. AKI Hemoptysis - Autoimmune Proportions

    34. Disparities in Clinical Research - Why & what can we do about it?

    35. Latest Insights into the Epidemiology of COVID-19 in Nephrology from ERACODA

    36. The Nephropathology of Drug Abuse

    37. The Pathology of Kidney Disease in Pregnancy

    38. Glomerular Disease in Pregnancy

    39. Let's Blow Glomerulopathy C3 Wide Open

    40. Advances in APOL1 Therapeutics

    41. AKI with Hematuria & Proteinuria in a Middle-aged Woman with a Solitary Kidney

    42. Renal Biopsy Pathology of IgA Nephropathy

    43. An Update on IgA Nephropathy Therapeutics

    44. Practical Pearls For Trial Recruitment: Perspective from two investigators and a patient

    1. Kidney Injury Post Stem Cell Transplant

    2. Magnetic Resonance Imaging to Assess Renal Tissue Oxygenation and Function A BOLD Story

    3. Lupus Nephritis Good News Stories

    4. An Interactive Live Exhibition from the Collection of Dr. Bijol

    5. Lupus Nephritis and Related Conditions

    6. New Glucose-Lowering Drugs and Kidney Protection in CKD

    7. The Renal Biopsy in the Era of Precision Medicine

    8. The Art of Treating ANCA Vasculitis

    9. Renal Toxicity Associated with New Immunotherapies

    10. Coronavirus Disease 2019 (COVID-19) Mitigation & Support Strategies in Patients with GN or Transplant

    11. Recurrent Glomerulonephritis - Lessons Learned from Recurrent Fibrillary Glomerulonephritis

    12. Coronavirus Disease 2019 (COVID-19) Mitigation & Support Strategies in Patients with CKD & ESRD

    13. PKD Throughout Life - ARPKD in Adults and ADPKD in Children

    14. FSGS

    15. Development and Validation of a Renal Risk Score in ANCA-Associated Glomerulonephritis

    16. Embracing the Heterogeneity of Nephrotic Syndrome

    17. Trends in Excess Mortality in European Adult Patients on Renal Replacement Therapy

    18. Diabetic Nephropathy

    19. Computational Nephropathology: From Basics to Applications - Applications of Computational Pathology to Nephropathology Research II by Dr. Pinaki Sarder and "Concluding Thoughts" by Dr. Tomaszewski

    20. When to Suspect MGRS in a Patient with Positive Monoclonal Studies?

    1. A Case-Based Clinicopathological Correlation

    2. Computational Nephropathology: From Basics to Applications - Applications of Computational Pathology to Nephropathology Research 1

    3. Lupus Nephritis

    4. C3 Glomerulopathy

    5. Sodium Bicarbonate and Cardiovascular Events in Hypertensive Adults: Results from SPRINT

    6. Computational Nephropathology: From Basics to Applications - Session 2: Basic principles of image analysis, segmentation, feature extraction

    7. Prognosis and Management of Primary FSGS - The Rush Experience

    8. The Startling Confessions of a Kidney Biopsy

    9. Pediatric GN Trials

    10. Computational Nephropathology: From Basics to Applications - Session 1: Computation Nephropathology - Introductions and Context

    11. Management of Membranous Nephropathy After MENTOR

    12. The Differential Diagnosis of Monoclonal Gammopathy of Renal Significance - "MGRS"

    13. FSGS

    14. Pathology Imaging and Informatics as the Cornerstone of Precision Medicine: Two years of Experience with the NIDDK Kidney Precision Medicine Project

    15. Urine Microscopy

    16. A Potpourri of Cases from the Collection of Dr. Bijol

    17. IgA Nephropathy

    18. FSGS: A Clinicopathological Correlation and Case-Based Approach Toward the Correct Diagnosis

    19. Clinical Presentation, Natural History, and Management of Inherited Disorders of Glomerular Basement Membrane

    20. ESRD Due to a History of GN - What Next?

    21. Genetic Causes of Glomerular Kidney Disease

    22. Clinical Trials 101

    23. The Pathology of Transplant Rejection

    24. Caffeine Consumption and Mortality in Chronic Kidney Disease: A Nationally Representative Analysis

    25. An Update on the Classification & Pathologic Diagnosis of MGRS Lesions

    26. Check Point Inhibitor Associated Renal Disease

    27. Tubulointerstitial Disorders in Systemic Disease

    28. The Spectrum of Lupus Nephritis: A Case Based Discussion

    29. CKD hotspots around the world; Nephropathies in Mesoamerica, the Balkans, and Southeast Asia

    30. Clinical Presentation, Differential Diagnosis, and Therapy of MGRS

    31. Pauci-immune Glomerulonephritis

    32. Risk Factors Associated with Post-Kidney Transplant Malignancy: Focusing on an Article from CKJ

    33. A Case-Based Approach to Diagnosis and Management of MGRS

    34. Can a Man Get Preeclampsia?

    35. Pathology of Paraprotein Mediated Kidney Disease

    36. Scleroderma Renal Crisis

    37. Clinical Presentation, Differential Diagnosis, and Therapy of Anti-GBM

    38. A Case-Based Approach to MPGN Pattern Injury and C3GN

    39. Crescentic GN - Anti-GBM

    40. Sudden Onset Nephrotic Syndrome and AKI in a Patient with HIV

    41. Tubulointerstitial Disorders

    42. Lupus Nephritis & Lupus Podocytopathy (Part 2)

    43. Onco-Nephrology Potpourri: A GlomCon Clinico-Pathological Correlation

    44. Clinical Presentation, Differential Diagnosis, and Therapy of Antiphospholipid Syndrome

    45. Renal Effects of Novel Oncologic Targeted and Immunotherapies

    46. Lupus Nephritis & Lupus Podocytopathy

    47. Focal Segmental Glomerulosclerosis - Beyond pathology, Should genetics guide our intervention?

    48. Clinical Presentation, Differential Diagnosis, and Therapy of TMA/TTP/HUS

    49. TMA/TTP/HUS - Scleroderma Renal Disease Antiphospholipid

    50. Current Status of Management of IgA Nephropathy

    51. The older adult receiving RRT: studies from the ERA-EDTA Registry

    52. The Clinicopathological Spectrum of Lupus Nephritis: A Case Based Approach to Diagnosis and Management

    53. IgA Nephropathy - Henoch-Schönlein Purpura

About this course

  • 287 lessons
  • 305.5 hours of video content